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Background: Chronic diarrhea in adults is a common symptom with a wide range of underlying etiologies.
Although various strategies have been proposed for evaluation, there are still cases with undetermined origins even
after extensive workup. Amyloidosis with gastrointestinal (GI) involvement is one of the causes that should be
considered in adult patients with chronic diarrhea. We report a case of primary systemic amyloid light-chain (AL)
amyloidosis, presenting initially as chronic diarrhea and weight loss.
Case presentation: A 43-year-old man with chronic diarrhea and weight loss was referred to our hospital. Prior to
his presentation, extensive evaluation including an exploratory laparotomy was carried out and did not yield any
valuable findings. An echocardiography performed after repeated episodes of orthostatic hypotension revealed
infiltrative cardiomyopathy. Moreover, biopsies of the terminal ileum revealed amyloid deposition confirmed by
Congo Red staining. Finally, a diagnosis of systemic AL amyloidosis was made after hematological workup. Anti-
plasma cell therapy did ameliorate his GI symptoms.
Conclusion: Although amyloidosis with GI involvement is a rare cause of chronic diarrhea, it should be considered
especially in patients with intestinal malabsorption and extra-GI manifestations, such as orthostatic hypotension. The
delayed diagnosis in the present case highlights the importance of recognizing clinical “red flags” not seemingly
related to one another, and underscores the need to get intestinal biopsies even with normal endoscopic
appearance of the mucosa.
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Chronic diarrhea is common with a prevalence of 3% to
5% in the general population [1]. The major causes of
chronic diarrhea can be assessed by combining a patient’s
history and characteristic of the stool (inflammatory, fatty
or watery). The differential diagnosis covers a wide range
of diseases from common encountered entities such as
chronic infection, inflammatory bowel disease, laxative
abuse, and irritable bowel syndrome to rare disorders.
Guidelines recommend categorizing chronic diarrhea as
osmotic, inflammatory, secretory or motile, which help
focus the diagnosis and further tests. Despite careful
evaluation of the differential diagnosis of chronic diarrhea,* Correspondence: yuelee76@gmail.com
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reproduction in any medium, provided the orphysicians can sometimes fail to recognize the cause. In
this case, physicians should take into consideration causes
less frequent or even rare diseases. In the present report, a
case of primary AL amyloidosis with GI involvement
presented as chronic diarrhea and weight loss. Although
similar conditions have been reported scantly [2,3], none
of them was initially diagnosed via random intestine bi-
opsy, and with a detailed therapeutic follow-up.
Case presentation
A 43-year-old man developed watery diarrhea that grad-
ually worsened over two years as well as progressive weight
loss of 35 kg.
He had an average stool frequency of up to 6 to 8 times
a day, with no obvious blood or mucus and no abdominal
pain or tenesmus. He had no fever, night sweats, nausea,
vomiting, hematochezia, or melena. Migrating tingling oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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earlier. During the past two years, he had undergone both
esophagogastroduodenoscopy (EGD) and colonoscopy
twice with normal appearance of the GI mucosa. Biopsy of
the intestine was not performed. Small bowel follow-
through as well as abdominal computed tomography (CT)
was unremarkable. In addition, an exploratory laparotomy
was performed 1 year ago with no diagnostic findings. It is
unknown whether in the previous period postural hypo-
tension had been observed or not. And the presence of
cardiomyopathy, sensorimotor peripheral neuropathy and
micturition disorders were also not highlighted in previ-
ous medical referrals.
The past medical history was remarkable for a diag-
nosed tuberculous pericarditis twenty years ago. Half a
year later, no obvious abnormality was detected by echo-
cardiography after treatment with standard anti-
tuberculosis regimen. No hypertrophic cardiomyopathy
was noticed.
On physical examination, his blood pressure was 94/
63 mmHg and pulse rate was 80 beats per minute. A mild
systolic murmur, grade 3/6, was heard at the aortic valve
area. The abdominal exam was normal and no lymphade-
nopathies were found.
Laboratory studies revealed anemia (hemoglobin 95 g/L,
reference value 120–160 g/L) with normal mean corpus-
cular volume (97.5 fL) of red blood cell, positive Sudan III
staining of the stool, mildly increased levels of serum cre-
atinine (120 μM, reference value 59–104 μM). Low density
lipoprotein was low (1.90 mM, reference value 2.07-
3.63 mM). Iron studies revealed a low serum iron level
(59.2 μg/dl, reference value 65–175 μg/dl), a slightly low
total iron-binding capacity (273 μg/dl, reference value
280–430 μg/dl) and an elevated ferritin level (669 ng/ml,
reference value 24–336 ng/ml). A D-xylose test revealed a
total excretion of 0.4 g in the five-hour collection of urine
(reference value more than 1.2 g). Serum electrolytes, total
protein, albumin, bilirubin, alkaline phosphatase, alanineFigure 1 Gastrointestinal endoscopic findings of the patient. Normal a
ileum (B).aminotransferase, γ-glutamyl transferase, glucose, amylase,
and lipase were all within normal limits. Microbiologic
and parasitologic analyses of the stools were negative. An-
tinuclear, anti-gliadin, anti-reticulin and anti-endomysial
antibodies were all negative. The patient was appropriately
evaluated for the most common endocrinologic causes of
diarrhea. Diabetes mellitus, hyperthyroidism and adrenal
insufficiency were excluded with the available medical his-
tory and laboratory tests. For a rare, but important class of
chronic secretory diarrheal illness caused by peptide-
secreting tumors (e.g. carcinoid tumors, VIPoma, gas-
trinoma), there was no remarkable suggestions after
extensive biochemical tests and imaging studies (CT scan
and somatostatin receptor scintigraphy).
The available data and the clinical picture first led us to
suspect an osmotic diarrhea associated with malabsorption.
However, even after a careful consideration of various
causes of diarrhea associated with malabsorption, it was
not possible to identify a cause that could confirm the
suspected diagnosis. Among the most common disorders
are lactose intolerance, giardiasis, celiac disease and bac-
terial overgrowth of the small intestines [4]. Rarely,
Whipple’s disease, microscopic colitis, eosinophilic gastri-
tis and lymphoma also manifest as chronic diarrhea [5]. In
these cases several random biopsies of the intestinal mu-
cosa during EGD and ileocolonoscopy are often decisive
in highlighting the pathological process of malabsorption.
EGD and ileocolonoscopy revealed normal appearance
of the GI mucosa (Figure 1). Before scheduled endoscopy
examination, the patient complained of several episodes of
dizziness when he passed from the supine to the upright
position. Orthostatic hypotension was confirmed and an
echocardiography was ordered to exclude heart disease.
The echocardiographic findings showed a hypertrophic
cardiomyopathy with a characteristic ground-glass ap-
pearance and thickening of the interventricular septum
(Figure 2). The random biopsies from the terminal ileum
revealed in the intestinal mucosa an eosinophilic amor-ppearance of the second part of duodenum (A) and the terminal
Figure 2 Echocardiographic findings of the patient. Apparent
left ventricular hypertrophy and “snowstorm” appearance of the
myocardium are suggestive of an infiltrative cardiomyopathy.
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for Congo red staining, even pretreated with potassium
permanganate before Congo red staining. Potassium per-
manganate treatment is a simple way to evaluate the
chemical type of amyloid protein. Such a pretreatment
does not affect staining affinity for Congo red in AL amyl-
oid but eliminates this affinity in AA amyloid, although
not in all cases [6]. The same biopsy examined under po-
larized light revealed apple-green birefringence, typical of
amyloid. Therefore we confirmed the diagnosis of sys-
temic amyloidosis with GI and cardiac involvement.
Primary or reactive amyloidosis was further differentiated.
Protein electrophoresis showed a narrow band formed by
paraprotein (M band). Immunofixation demonstrated it as
IgG-lambda type in both serum and urine specimens. Fur-
ther laboratory studies revealed decreased serum immuno-
globulin levels (IgA 0.35 g/L, reference value 0.7-3.8 g/L;
IgM 0.26 g/L, reference value 0.6-2.5 g/L), elevated
free lambda light-chain levels, and an abnormal ratio
of free kappa to free lambda light chains. Myelogram
revealed a marrow plasmacytosis of 11.5%. X-rays didFigure 3 Microscopic findings of the terminal ileum biopsy. Hematoxy
amorphous material consistent with amyloid. Original magnification, ×100not show any skeletal osteolytic lesions. The final diag-
nosis was systemic AL amyloidosis IgG lambda-type BJ
positive lambda.
Before the final diagnosis was reached, the control of
the diarrhea (a stool frequency of 1 to 2/day) was attained
with diosmectite and loperamide. Then, after the diagnosis
was made, a chemotherapy regimen (bortezomib, dexa-
methasone and thalidomide) was initiated and continued
for four courses, achieving a good clinical response. The
stool frequency was 1 to 2/day after discontinuation of
anti-diarrhea medications. Serum creatinine level was
around 80 μM. At the last follow up, the patient had
gained 6 kg in weight.
Conclusions
Amyloidosis is a generic term that refers to a heteroge-
neous group of diseases, characterized by the deposition
of misfolded fibrils in various tissues. In each type of
amyloidosis, a different protein produced by the body
acquires the property to accumulate in different organs
and tissues in the form of fibrils. Systemic AL amyloid-
osis is the most common type, associated with plasma
cell dyscrasia, which produces immunoglobulin light
chain that is amyloidogenic. The secondary amyloidosis
is due to amyloid formed from serum amyloid A (AA),
an acute-phase protein produced in response to inflam-
mation. For familial amyloidosis, the most frequent type
seen on tertiary referral centers is caused by mutant
transthyretin (TTR) deposition. The clinical manifesta-
tions depend on the number and nature of organs af-
fected, in which GI involvement is quite rare. GI
amyloidosis is more common in reactive amyloidosis,
but was also reported in primary amyloidosis, with
prevalence about 1% in a retrospective cohort [7]. Pri-
mary amyloidosis usually presents with constipation,
mechanical obstruction, while reactive amyloidosis pre-
sents with diarrhea and malabsorption [8]. However, for
this patient, GI involvement did explain his chroniclin and eosin staining shows extracellular deposits of eosinophilic
(A) and ×200 (B).
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accordance with the layer of bowel wall involved. Mu-
cosa predominant disease is manifested as malabsorp-
tion, whereas muscularis predominant disease presents
as obstruction. Autonomic neuropathy may also affect
gut function, which was distinguished in GI symptoms
caused by mutant transthyretin amyloidosis [9]. In our
patient, the malabsorption was considered as a compre-
hensive result of his specific pathological changes. In
addition, the orthostatic hypotension and moderate renal
insufficiency suggested cardiac and renal involvement.
The migratory tingling in the history may be also due to
peripheral neuropathy-induced by amyloid deposition.
After the diagnosis was established treatment was di-
rected to the hematological cause, namely plasma cell
dyscrasia. GI symptoms, especially diarrhea, were greatly
improved after four courses of chemotherapy, which
should be mainly attributed to the anti-plasma cell ther-
apy with decreased production of amyloid proteins [10].
Also noteworthy is the need to maintain special precau-
tions in the use of thalidomide and bortezomib for their
common adverse effects reducing the intestinal motility
[11]. The renal insufficiency of this patient also remitted,
since bortezomib has become a standard regimen ther-
apy for these patients [12].
In summary, the diagnostic proceeding of this patient
emphasizes the need of a stepwise integration of results
from detailed medical history, physical examination, la-
boratory and imaging studies, focusing generally on the
malabsorption syndrome. Even in this way, the diagnosis
of amyloidosis is still difficult to confirm. The delay from
onset of symptoms to diagnosis was from 7 to 24 months
in a retrospective study and could be due either to the
patient’s or to the physician’s delay [13]. The reason for
the physician’s delay is only partly due to the rarity of
the disease. In fact, the onset of clinical signs or symp-
toms at different times considered to be non-specific will
become decisive factors for the orientation towards a
correct diagnosis, if the doctor could relate them to each
other. Panels of differential diagnoses are certainly very
useful. It should be stressed that some symptoms (if
reported or recognized), seemingly unrelated to each
other, are actually early and specific red flags of the
amyloid process. In this patient, the differential diagnosis
was transformed from a broad question into a narrow
one after the orthostatic hypotension was noticed. How-
ever, other characteristic clinical signs of a possible
amyloidosis could have been recognized previously in
addition to malabsorption and diarrhea (gastrointestinal
illness). These include migrating tingling of lower ex-
tremities (neuropathy disease), hypertrophic cardiomy-
opathy (heart disease), renal failure (kidney disease),
anemia and monoclonal gammopathy (hematologic dis-
ease). Each of these aspects can cause a patient toconsult doctors of different specialties, making it difficult
to achieve an accurate early diagnosis. Increasing med-
ical alertness of the natural history of the systemic amy-
loidosis could reduce the time to achieve the diagnosis
and therapeutic decisions, also improving the prognosis.
Finally, it could allow physicians to reach the correct
diagnosis earlier and achieve a (serendipitous) positive
biopsy result obtained from the random intestinal biopsy
even with normal endoscopic appearance.
Moreover, it is useful to emphasize that even without
histological evidence in the first diagnostic approach, if
the clinician has a solid suspect of amyloidosis, before
abandoning this hypothesis, it is necessary to verify data
with “perseverance”, in order to control the correct cri-
teria and results with ambiguous diagnostic evidence.
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